| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 670664 | Null | 0.045446901295916 | 0.33602417 |
| NSC 616511 | Null | 0.0454469012959166 | -0.012021286 |
| NSC 678925 | 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride | 0.0454469012959173 | 0.19061843 |
| NSC 679001 | 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- | 0.0454469012959173 | 0.095417318 |
| NSC 679800 | Null | 0.0454469012959173 | 0.32632443 |
| NSC 681645 | Camptothecin Derivative | 0.0454469012959173 | 0.069832928 |
| NSC 696257 | 2,3-Dihydro-1,2-syn-2-[S-(L)-cysteinylsulfoxide-]-brefeldin A | 0.0454469012959173 | -0.016874665 |
| NSC 699412 | Null | 0.0454469012959173 | 0.1660606 |
| NSC 701378 | 3-Pyridinecarbonitrile, 4-(4-chlorophenyl)- 6-[4-[[7-(trifluoromethyl)-4-quinolinyl]amino]phenyl]- 1,2-dihydro-2-oxo- | 0.0454469012959173 | 0.061374695 |
| NSC 703855 | Null | 0.0454469012959173 | 0.13126731 |